Infusion Pump Market is anticipated to grow at a CAGR of 7.3% during the forecast period 2021-2031

The infusion pumps market was valued at USD 9.7 billion in 2021 and it is anticipated to grow further to USD 19.7 billion by 2031, at a CAGR of 7.3% during the forecast period.

Global Infusion Pump Market report from Global Insight Services is the single authoritative source of intelligence on Infusion Pump Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Request Sample Report : https://www.globalinsightservices.com/request-sample/GIS10307

Medications, hormones, and nutritious fluids are administered into the circulatory system through veins in controlled volumes using intravenous infusion pumps. In clinical settings including hospitals, nursing homes, and homes, these pumps are widely used. Using built-in software, the skilled operator controls the pump by setting the rate and duration of fluid supply. Nutrients, hormones, antibiotics, chemotherapeutic medications, and painkillers can all be given by intravenous infusion pumps.

Market Trends and Drivers

The number of surgical operations carried out worldwide has significantly increased over time. The growing elderly population, as well as the increased frequency of obesity and other lifestyle disorders, are both responsible for this. One of the main causes of orthopedic and cardiovascular disorders is obesity. Obesity also raises the risk of ischemic stroke, type 2 diabetes mellitus, joint and tissue damage, breast, colon, ovarian, endometrial, kidney, and gallbladder cancer. The continuous and controlled medicine administration during and following many types of surgeries is made possible by infusion pumps. Diabetes, analgesia/pain management, gastroenterology, and chemotherapy are the main applications for infusion pumps. Infusion pumps are also frequently used to administer narcotic analgesics and anesthesia locally after cardiothoracic surgery, laparoscopic cholecystectomy, and bariatric surgery. The demand for infusion therapy is anticipated to rise as the number of procedures conducted does.

Market Restraints and Challenges

Infusion pumps are intended to administer liquid medications and other solutions to a patient’s body. They must adhere to certain regulations and guidelines in order to safeguard patients’ health and safety. For the approval of new goods, the infusion pump market is governed by a number of regulatory agencies, including the US Food and Drug Administration (FDA), the Medicines and Healthcare Products Regulatory Agency (MHRA), and the European Medicines Agency (EMA). In order to lawfully sell and promote infusion pumps in European nations, the CE mark certification is required. Non-implantable infusion pumps are categorized as Class II b devices, while implantable infusion pumps are categorized as Active Implantable Medical Devices (AIMD). There are over 300 standards for medical equipment that are unique to the UK.

Buy Now : https://www.globalinsightservices.com/checkout/single_user/GIS10307

Global Infusion Pumps Market Segmentation

By Type

  • Volumetric Pumps
  • Syringe Pumps
  • Elastomeric Pumps
  • Insulin Pumps
  • Enteral Pumps
  • Implantable Pumps
  • Patient Control Analgesia Pumps

By Application

  • Diabetes
  • Oncology
  • Pain Management
  • Others
Major Players in the Global Infusion Pumps Market

The key players studied in the Becton, Dickinson and Company (US), Baxter International (US), B. Braun (Germany), ICU Medical (US), Fresenius Kabi (Germany), Medtronic PLC (Ireland), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Terumo Corporation (Japan), Insulet Corporation (US), Ypsomed Holding AG (Switzerland), Tandem Diabetes Care (US), JMS Co., Ltd. (Japan) and Micrel Medical Devices SA (Greece) among others.

Request For Customization : https://www.globalinsightservices.com/request-customization/GIS10307

With Global Insight Services, you receive:

• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/